Aida Pharmaceuticals OTC Pink Sheet Buy Hold or Sell Recommendation

AIDA
 Stock
  

USD 0.0003  0.00  0.00%   

Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Aida Pharmaceuticals is 'Strong Sell'. Macroaxis provides Aida Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AIDA positions. The advice algorithm takes into account all of Aida Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Aida Pharmaceuticals' buy-and-hold perspective. Please continue to Aida Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Aida Pharmaceuticals and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Aida Pharmaceuticals.

Execute Aida Pharmaceuticals Buy or Sell Advice

The Aida Pharmaceuticals recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aida Pharmaceuticals. Macroaxis does not own or have any residual interests in Aida Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aida Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Aida PharmaceuticalsBuy Aida Pharmaceuticals
Strong Sell

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Not Available
Details

Reporting Quality (M-Score)

Details
For the selected time horizon Aida Pharmaceuticals has a Mean Deviation of 1.49, Standard Deviation of 6.15 and Variance of 37.88
We provide trade advice to complement the prevailing expert consensus on Aida Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Aida Pharmaceuticals is not overpriced, please confirm all Aida Pharmaceuticals fundamentals, including its revenue, cash and equivalents, and the relationship between the price to earning and ebitda . As Aida Pharmaceuticals appears to be a penny stock we also recommend to validate its price to sales numbers.

Aida Pharmaceuticals Trading Alerts and Improvement Suggestions

Aida Pharmaceuticals is way too risky over 90 days horizon
Aida Pharmaceuticals has some characteristics of a very speculative penny stock
Aida Pharmaceuticals appears to be risky and price may revert if volatility continues
Aida Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company currently holds 41.17 M in liabilities with Debt to Equity (D/E) ratio of 2.37, implying the company greatly relies on financing operations through barrowing. Aida Pharmaceuticals has a current ratio of 0.72, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Aida Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Aida Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aida Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aida Pharmaceuticals to invest in growth at high rates of return. When we think about Aida Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 40.51 M. Net Loss for the year was (2.18 M) with profit before overhead, payroll, taxes, and interest of 14.64 M.

Aida Pharmaceuticals Returns Distribution Density

The distribution of Aida Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Aida Pharmaceuticals' future price movements. The chart of the probability distribution of Aida Pharmaceuticals stock daily returns describes the distribution of returns around its average expected value. We use Aida Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aida Pharmaceuticals returns is essential to provide solid investment advice for Aida Pharmaceuticals.
Mean Return0.76Value At Risk0.00
Potential Upside0.00Standard Deviation6.15
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aida Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Aida Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aida Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aida Pharmaceuticals' price will be affected by overall otc pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aida Pharmaceuticals otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.80
β
Beta against NYSE Composite-0.73
σ
Overall volatility
6.35
Ir
Information ratio 0.11

Aida Pharmaceuticals Volatility Alert

Aida Pharmaceuticals is displaying above-average volatility over the selected time horizon. Investors should scrutinize Aida Pharmaceuticals independently to ensure intended market timing strategies are aligned with expectations about Aida Pharmaceuticals volatility. Aida Pharmaceuticals appears to be a penny stock. Although Aida Pharmaceuticals may be, in fact, a solid short-term or long term investment, many penny otc pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Aida Pharmaceuticals or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Aida Pharmaceuticals instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Aida Pharmaceuticals Fundamentals Vs Peers

Comparing Aida Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aida Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Aida Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aida Pharmaceuticals or determine the otc pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Aida Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aida Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Aida Pharmaceuticals to competition
FundamentalsAida PharmaceuticalsPeer Average
Return On Equity(1.79) %(0.31) %
Return On Asset6.62 %(0.14) %
Profit Margin(5.38) %(1.27) %
Operating Margin17.34 %(5.51) %
Current Valuation41.09 M16.62 B
Price to Earning(0.25) X28.72 X
Price to Sales0.62 X11.42 X
Revenue40.51 M9.43 B
Gross Profit14.64 M27.38 B
EBITDA9.51 M3.9 B
Net Income(2.18 M)570.98 M
Cash and Equivalents8.28 M2.7 B
Cash per Share0.31 X5.01 X
Total Debt41.17 M5.32 B
Debt to Equity2.37 %48.70 %
Current Ratio0.73 X2.16 X
Book Value Per Share0.34 X1.93 K
Cash Flow from Operations7.49 M971.22 M
Earnings Per Share(0.08) X3.12 X
Number of Employees45018.84 K
Beta17.6-0.15
Market Capitalization25.11 M19.03 B
Total Asset73.99 M29.47 B
Retained Earnings2.75 M9.33 B
Working Capital(12.09 M)1.48 B
Current Asset32.28 M9.34 B
Current Liabilities44.37 M7.9 B

About Aida Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Aida Pharmaceuticals? Buying financial instruments such as Aida Pharmaceuticals OTC Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Aida Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Banking Thematic Idea Now

Banking
Banking Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Aida Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Aida Pharmaceuticals information on this page should be used as a complementary analysis to other Aida Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Aida Pharmaceuticals OTC Pink Sheet analysis

When running Aida Pharmaceuticals price analysis, check to measure Aida Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aida Pharmaceuticals is operating at the current time. Most of Aida Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aida Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aida Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aida Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Please note, there is a significant difference between Aida Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Aida Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aida Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.